DERM stock · TECH stock

DERM vs TECH

Journey Medical Corp (DERM) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.

Journey Medical Corp (DERM) is a drug manufacturers - specialty & generic company listed on US.

Bio-Techne Corp (TECH) is a biotechnology company listed on US.

Latest reported DERM revenue for 2024-12-31 was $56.1M. Net income was -$14.7M. Revenue was down 29.1% from 2023-12-31 to 2024-12-31. DERM currently screens at market cap $163.1M.

Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.

DERM currently screens at market cap $163.1M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.

Not investment advice. Open the DERM and TECH stock pages for the full models.

Not investment advice.

Popular Stock Comparisons